Totally. Hard to fathom how we can have ~$300m in the bank, enough revenue from interest alone to cover outgoings, increasing revenue and possible milestones, not to mention a free crack at what I consider to be a Blockbuster drug (multiple blockbusters in my humble opinion), and we are ONLY worth double the company with limited money, limited revenue and terrible trial outcomes.
I take no delight whatsoever in saying that, just stating the fact. Seems really hard to reconcile our valuation, which is why ever spare $ I have goes into buying more shares when I can.
NEU Price at posting:
$12.39 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)